Hepatitis B Virus
Data on hepatitis B virus published by researchers at Yonsei University, Medical Department
Published in Hepatitis Weekly, May 26th, 2008
According to a study from Seoul, South Korea, "Monotherapy of lamivudine, interferon-alpha (IFN-alpha), and thymosin alpha-1 (T alpha 1) is unlikely to be sufficient for the eradication of a chronic hepatitis B virus ( HBV) infection. The aim of our study is to elucidate whether the combination of Ta1 and lamivudine is superior to lamivudine monotherapy in hepatitis B e antigen ( HBeAg) positive naive patients with chronic hepatitis B. Sixty-seven patients were assigned to two different groups in a randomized manner."
"The combination group (n = 34) received Ta1 (1.6 mg subcutaneously, twice a week) and lamivudine ( 100 mg orally, daily) for 24 weeks, followed by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-05-26)
More Articles from Hepatitis Weekly
- Acute Hepatitis
Research in the area of acute hepatitis reported from K. Kusumoto and colleagues - Cholangio Cancer
Study results from L.L. Guo and colleagues update understanding of cholangio cancer - Diabetes
Data from D.L. Segev et al provide new insights into diabetes - Enzyme Research
New enzyme research findings from L.V. Jukic and co-researchers published - Hepatitis B Virus
Data from Erasmus University advance knowledge in hepatitis B virus - Hepatitis B Virus
Investigators at Georgetown University have published new data on hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
